No developmental toxicities were observed in rabbits at doses up to 180 mg/kg/day (1191-times the 10 mg clinical dose, based on AUC)
Alluvi supplies Retatrutide pens exclusively for laboratory research and development
Although semaglutide is licensed for use only in people with obesity suffering health problems, specialists can legally offer it to anyone they feel might benefit this is known as off-label use
JorsalAKistorpCHolmagerPTougaardRSNielsenRHnselmannAet alEffect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
Experts say its common for people to have side effects with GLP-1s
While the FDA has not yet approved retatrutide, we recommend consulting with a healthcare provider or our team of experts at the biostation if it's something you're interested in learning more about